FdaApplication
ANDA 214753
Identifiers
- fda_app_no: ANDA214753
Properties
| Property | Value |
|---|---|
| applicant_name | ALKEM LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2021-03-12 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SIROLIMUS | SIROLIMUS | 2MG | TABLET;ORAL |
| SIROLIMUS | SIROLIMUS | 1MG | TABLET;ORAL |
| SIROLIMUS | SIROLIMUS | 0.5MG | TABLET;ORAL |
3 products